hVIVO (LON:HVO) Trading 9.5% Higher - What's Next?

hVIVO plc (LON:HVO - Get Free Report) shares shot up 9.5% during mid-day trading on Friday . The company traded as high as GBX 15.75 ($0.20) and last traded at GBX 15.61 ($0.20). 1,709,755 shares changed hands during trading, a decline of 48% from the average session volume of 3,283,339 shares. The stock had previously closed at GBX 14.25 ($0.18).

hVIVO Trading Down 1.4 %

The stock has a market capitalization of £103.31 million, a P/E ratio of 6.02 and a beta of 0.97. The stock's fifty day moving average price is GBX 16.22 and its 200 day moving average price is GBX 20.93. The company has a debt-to-equity ratio of 33.86, a current ratio of 1.61 and a quick ratio of 1.16.

Insiders Place Their Bets

In other news, insider Yamin Mo' Khan sold 3,062,246 shares of the stock in a transaction on Thursday, March 6th. The stock was sold at an average price of GBX 17 ($0.22), for a total transaction of £520,581.82 ($665,195.27). Insiders own 14.03% of the company's stock.

hVIVO Company Profile

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.